Literature DB >> 20061579

The PA projection of the clavicle: a dose-reducing technique.

Mark F Mc Entee1, Catherine Kinsella.   

Abstract

This study compares dose and image quality during PA and AP radiography of the clavicle. The methodology involved a cadaver-based dose and image quality study. Results demonstrate a statistically significant 56.1 % (p <or= 0.001) and 56.5 % (p <or= 0.001) reductions to breast tissue and 62.3 % (p <or= 0.001) and 78 % (p <or= 0.001) reductions in the thyroid dose with employment of PA and PA15 caudal projections. Reductions of 28.5 % (p <or= 0.08) and 11.8 % (p <or= 0.12) in the doses to the eye were demonstrated for the PA. Differences in entrance-surface and exit doses were deemed non-significant. A 5.9 % (p <or= 0.39) reduction in overall image quality was seen with PA positioning. Reductions in image quality were evaluated to be non-significant at 95 % (AP vs PA (p <or= 0.06), AP15 degrees Vs PA15 degrees (p <or= 0.28). The current study demonstrated consistent significant dose reductions to the thyroid and breast when PA projection is chosen over the AP projection. The authors recommend the implementation of PA positioning for clavicle radiography.

Entities:  

Mesh:

Year:  2010        PMID: 20061579     DOI: 10.1093/rpd/ncp291

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  3 in total

1.  Lumbar spine radiographs - is it time for widespread adoption of posteroanterior projection?

Authors:  Christopher Green; Guru Karnati; Katharine Thomson; Ashok Subramanian
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

2.  Reduction of radiation risks in patients undergoing some X-ray examinations by using optimal projections: A Monte Carlo program-based mathematical calculation.

Authors:  A Chaparian; A Kanani; M Baghbanian
Journal:  J Med Phys       Date:  2014-01

3.  Comparison of anteroposterior and posteroanterior projection in lumbar spine radiography.

Authors:  Erna Alukic; Damijan Skrk; Nejc Mekis
Journal:  Radiol Oncol       Date:  2018-05-14       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.